Association between patient-provider communication and lung cancer stigma
- 657 Downloads
The majority (95 %) of lung cancer patients report stigma, with 48 % of lung cancer patients specifically reporting feeling stigmatized by their medical providers. Typically associated with the causal link to smoking and the historically poor prognosis, lung cancer stigma can be seen as a risk factor for poor psychosocial and medical outcomes in the context of lung cancer diagnosis and treatment. Thus, modifiable targets for lung cancer stigma-reducing interventions are needed. The present study sought to test the hypothesis that good patient-provider communication is associated with lower levels of lung cancer stigma.
Lung cancer patients (n = 231) across varying stages of disease participated in a cross-sectional, multisite study designed to understand lung cancer stigma. Patients completed several survey measures, including demographic and clinical characteristics, a measure of patient-provider communication (Consumer Assessment of Healthcare Providers and Systems Program or CAHPS), and a measure of lung cancer stigma (Cataldo Lung Cancer Stigma Scale).
As hypothesized, results indicated that good patient-provider communication was associated with lower levels of lung cancer stigma (r = −0.18, p < 0.05). These results remained significant, even when controlling for relevant demographic and clinical characteristics (Stan. β = −0.15, p < 0.05).
Results indicate that good patient-provider communication is associated with lower levels of lung cancer stigma, suggesting that improving patient-provider communication may be a good intervention target for reducing lung cancer stigma.
KeywordsLung cancer Lung cancer stigma Patient-provider communication
Compliance with ethical standards
This work was supported by the following grants: National Cancer Institute (T32-CA009461), National Cancer Institute (1R03CA154016), the North Carolina Chapter (Young Investigator Award), and the Lung Cancer Research Foundation.
UL1TR001105 (National Center for Advancing Translational Sciences, NIH).
- 1.Bell K, Salmon A, Bowers M, Bell J, McCullough L (2010) Smoking, stigma and tobacco ‘denormalization’: further reflections on the use of stigma as a public health tool. A commentary on Social Science & Medicine’s Stigma, Prejudice, Discrimination and Health Special Issue. Soc Sci Med 70(6):795–799CrossRefPubMedGoogle Scholar
- 4.Hamann HA, Howell LA, McDonald JL. Causal attributions and attitudes toward lung cancer. Journal of Applied Social Psychology. 2013Google Scholar
- 7.Hamann HA, Ostroff JS, Marks EG, Gerber DE, Schiller JH, Lee SJC. Stigma among patients with lung cancer: a patient reported measurement model. Psycho‐Oncology. 2013Google Scholar
- 10.Holland JC, Kelly BJ, Weinberger MI (2010) Why psychosocial care is difficult to integrate into routine cancer care: stigma is the elephant in the room. J Natl Compr Cancer Netw 8(4):362–366Google Scholar
- 32.Willms DG, Best J, Wilson D et al (1990) Patients’ perspectives of a physician-delivered smoking cessation intervention. Am J Prev Med 7(2):95–100Google Scholar